SCHEMBL5030692

SCHEMBL5030692

O=C(O)CC(CC(=O)O)(OC(=O)O)C(=O)O.[MgH2]

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.44
HIF1A Q16665 2/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
ALDH1A1 P00352 1/20 0.40
HMGCR P04035 1/20 0.40
CHRM1 P11229 1/20 0.40
TBXA2R P21731 1/20 0.40
ADRA1A P35348 1/20 0.40
CPT2 P23786 2/20 0.34
KDM4E B2RXH2 1/20 0.34
FFAR1 O14842 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
ACLY P53396 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1547881 0.97 CYP2C19 (0.46) CYP2C19HIF1ACYP2D6TSHRALDH1A1
Ammonia Solution, Strong SCHEMBL19976105 0.95 CYP2C19 (0.44) CYP2C19HIF1ACYP2D6TSHRALDH1A1
Bicarbonate SCHEMBL18954885 0.95 CYP2C19 (0.44) CYP2C19HIF1ACYP2D6TSHRALDH1A1
SCHEMBL28887606 0.95 CYP2C19 (0.44) CYP2C19HIF1ACYP2D6TSHRALDH1A1
SCHEMBL27902708 0.95 CYP2C19 (0.44) CYP2C19HIF1ACYP2D6TSHRALDH1A1
SCHEMBL8352054 0.95 CYP2C19 (0.44) CYP2C19HIF1ACYP2D6TSHRALDH1A1
SCHEMBL20912559 0.95 CYP2C19 (0.44) CYP2C19HIF1ACYP2D6TSHRALDH1A1
SCHEMBL10621210 0.95 CYP2C19 (0.44) CYP2C19HIF1ACYP2D6TSHRALDH1A1
Citric Acid SCHEMBL7937488 0.89 ALDH1A1 (0.60) CYP2C19HIF1ACYP2D6TSHRALDH1A1
Bicarbonate SCHEMBL6944573 0.89 CYP2C19 (0.39) CYP2C19HIF1ACYP2D6TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109310774-A Containing can sulfate and magnesium citrate liquid preparation 费林股份公司 2019-02-05 CN disclosed
EP-1940316-A2 PRESSURE ATTENUATION DEVICE Solace Therapeutics, Inc. (US) 2008-07-09 EP disclosed
WO-2007038476-A9 PRESSURE ATTENUATION DEVICE ATTENEUX TECHNOLOGIES INC (US) 2008-04-03 WO disclosed
EP-1572285-A4 IMPLANTABLE PRESSURE ATTENUATION DEVICE SOLACE THERAPEUTICS INC (US) 2007-09-05 EP disclosed
WO-2007038476-A2 PRESSURE ATTENUATION DEVICE ATTENEUX TECHNOLOGIES, INC. (US) 2007-04-05 WO disclosed
EP-1572285-A2 IMPLANTABLE PRESSURE ATTENUATION DEVICE Solace Therapeutics, Inc. (US) 2005-09-14 EP disclosed
WO-2004030518-A2 IMPLANTABLE PRESSURE ATTENUATION DEVICE SOLACE THERAPEUTICS, INC. (US) 2004-04-15 WO disclosed
EP-0837703-A4 APPARATUS FOR CONTROLLED FLUID DELIVERY RIVER MEDICAL INC (US) 1999-08-25 EP disclosed
EP-0837703-A1 APPARATUS FOR CONTROLLED FLUID DELIVERY RIVER MEDICAL, INC. (US) 1998-04-29 EP disclosed
WO-1997002849-A1 APPARATUS FOR CONTROLLED FLUID DELIVERY RIVER MEDICAL, INC. (US) 1997-01-30 WO disclosed
EP-0748252-A1 GAS DELIVERY APPARATUS AND COMPOSITIONS FOR INFUSION RIVER MEDICAL, INC. (US) 1996-12-18 EP disclosed
WO-1995023641-A1 GAS DELIVERY APPARATUS AND COMPOSITIONS FOR INFUSION RIVER MEDICAL, INC. (US) 1995-09-08 WO disclosed